Bakhos A Tannous Selected Research

obtusaquinone

1/2020	Obtusaquinone: A Cysteine-Modifying Compound That Targets Keap1 for Degradation.
1/2020	The natural compound obtusaquinone targets pediatric high-grade gliomas through ROS-mediated ER stress.
5/2013	Targeting cancer cells with the natural compound obtusaquinone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bakhos A Tannous Research Topics

Disease

53	Neoplasms (Cancer) 02/2024 - 05/2006
21	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 06/2009
15	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2009
14	Glioma (Gliomas) 01/2020 - 11/2008
5	Breast Neoplasms (Breast Cancer) 12/2021 - 11/2012
5	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2009
3	Inflammation (Inflammations) 01/2021 - 09/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2016
2	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 12/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 01/2018
2	Multiple Sclerosis 10/2020 - 07/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2020 - 01/2019
2	Infections 01/2020 - 05/2009
2	AIDS-Related Complex (ARC) 12/2016 - 06/2015
1	Central Nervous System Diseases (CNS Diseases) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Down Syndrome (Down's Syndrome) 09/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 12/2019
1	Astrocytoma (Pilocytic Astrocytoma) 12/2019
1	Hydrocephalus (Hydrocephaly) 12/2019
1	Autistic Disorder (Autism) 12/2019
1	Intellectual Disability (Idiocy) 12/2019
1	Epilepsy (Aura) 12/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Medulloblastoma 06/2016
1	Disease Progression 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2008
11	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2009
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2009
7	LuciferasesIBA 01/2019 - 05/2008
6	LigandsIBA 01/2018 - 06/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016 - 06/2011
4	tetraethylpyrazine (TEP)IBA 12/2022 - 11/2015
4	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2009
4	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 01/2014
3	Peptides (Polypeptides)IBA 01/2022 - 06/2015
3	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2008
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2018
3	obtusaquinoneIBA 01/2020 - 05/2013
3	lanatoside CIBA 04/2016 - 11/2011
3	Cardiac GlycosidesIBA 04/2016 - 06/2011
3	StreptavidinIBA 11/2015 - 05/2006
2	trans-sodium crocetinate (crocetin)IBA 01/2021 - 12/2019
2	Tuberous Sclerosis Complex 1 ProteinIBA 01/2021 - 12/2019
2	Tuberous Sclerosis Complex 2 ProteinIBA 01/2021 - 12/2019
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2020 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 08/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2018
2	Biotin (Vitamin H)FDA Link 12/2016 - 11/2015
2	Angiogenesis InhibitorsIBA 01/2016 - 04/2009
2	coelenterazineIBA 01/2016 - 03/2012
2	Messenger RNA (mRNA)IBA 11/2015 - 11/2009
2	Phosphotransferases (Kinase)IBA 01/2014 - 09/2010
2	Lapatinib (GW572016)FDA Link 11/2012 - 12/2009
2	Transcription Factors (Transcription Factor)IBA 01/2012 - 09/2009
2	3-deazaneplanocinIBA 01/2011 - 12/2010
2	Glutamic Acid (Glutamate)FDA Link 06/2009 - 05/2008
1	butylidenephthalideIBA 09/2022
1	I-antigenIBA 01/2022
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 01/2022
1	Odorant Receptors (Odorant Receptor)IBA 12/2021
1	ORALIT (ORS)IBA 12/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	CytokinesIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 02/2020
1	VimentinIBA 01/2020
1	plerixafor FDA Link 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	uracil phosphoribosyltransferaseIBA 01/2019
1	Lipid NanoparticlesIBA 01/2019
1	Cytosine DeaminaseIBA 01/2019
1	Flucytosine (Ancobon)FDA Link 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Cyclic PeptidesIBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	ProdrugsIBA 01/2019
1	AntigensIBA 01/2019
1	MethyltransferasesIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	Alkylating AgentsIBA 01/2018
1	O-(6)-methylguanineIBA 01/2018
1	Leptin ReceptorsIBA 12/2016
1	QuercetinIBA 06/2016
1	FlavonoidsIBA 06/2016
1	CrizotinibIBA 01/2016

Therapy/Procedure

31	Therapeutics 01/2023 - 04/2009
4	Radiotherapy 02/2024 - 06/2016
4	Drug Therapy (Chemotherapy) 01/2020 - 05/2013
3	Immunotherapy 01/2019 - 07/2013
2	Intravenous Administration 01/2018 - 01/2016
1	Precision Medicine 01/2023
1	Neoadjuvant Therapy 02/2020
1	Autologous Transplantation 01/2019